Riyaz Shah, BSc(Hons), MBBS, FRCP, PhD, Kent Oncology Centre, UK, discusses the role of immunotherapy for the treatment of patient with mesothelioma. The Phase III CHECKMATE-743 (NCT02899299) study highlighting the benefit of immunotherapy in the first-line setting. This interview took place at the BTOG 2022 Summer Meeting congress in London.
